Replies to post #2525 on Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109

Zoriden you were right news came

FDA approves IND for RXI-109 in retinal scarring of advanced macular degeneration patients

http://finance.yahoo.com/news/rxi-pharmaceuticals-announces-advancements-ophthalmology-110200017.html